For adults with advanced melanoma
OPDIVO® (nivolumab) is a prescription medicine used to treat adults with a type of skin cancer called melanoma that has spread or cannot be removed by surgery (advanced melanoma).
OPDIVO is a prescription medicine used in combination with YERVOY® (ipilimumab) to treat adults with a type of skin cancer called melanoma that has spread or cannot be removed by surgery (advanced melanoma).
It is not known if OPDIVO is safe and effective in children younger than 18 years of age.
A CHANCE TO
LIVE LONGER™
OPDIVO® and OPDIVO + YERVOY®
are approved for advanced melanoma regardless of BRAF biomarker status
In an analysis of 945 previously untreated advanced melanoma patients, 314 received a combination of OPDIVO + YERVOY, 316 received OPDIVO alone, and 315 received YERVOY alone.
WATCH ROBERTO'S ADVANCED MELANOMA STORY
Tap to watch
this video 
OPDIVO + YERVOY TRIAL RESULTS
IN A FOLLOW-UP ANALYSIS FOR THIS STUDY
7.5 YEARS
At the 7.5 year follow-up analysis, OPDIVO + YERVOY reduced the risk of dying by 47% compared to YERVOY. At the primary analysis at 28 months, OPDIVO + YERVOY reduced the risk of dying by 45% compared to YERVOY alone and half of the patients on OPDIVO + YERVOY were alive at 72.1 months, compared to 19.9 months with YERVOY.
A separate analysis looked at results by BRAF status
OPDIVO TRIAL RESULTS
IN A FOLLOW-UP ANALYSIS FOR
THIS STUDY
The follow-up analysis at 7.5 years is consistent with the earlier (primary) analysis at 28 months. At 28 months, OPDIVO reduced the risk of dying by 37% compared to YERVOY alone. Half of the patients on OPDIVO were alive at 36.9 months, compared to 19.9 months with YERVOY.
A separate analysis looked at results by BRAF status
OPDIVO and OPDIVO + YERVOY will not work for everyone. Individual results may vary.
Please select an option below
to
see additional clinical trial information
WATCH AN ONCOLOGY NURSE AND HER PATIENT DISCUSS STARTING TREATMENT
Watch a video of an oncology nurse speaking to one of her patients with the hope that it may help other patients on their treatment journey.
WATCH REAL PATIENTS
SHARE THEIR STORIES
Every patient or family member
has a story to tell. See
videos
that feature real patients,
caregivers, and family members
who describe their experiences on
an OPDIVO treatment.
SIGN UP FOR
Complimentary support, tools,
and educational resources
for anyone
considering or currently taking
OPDIVO.
Call 1-855-OPDIVO-1 or
click to learn more.
HAVE YOU DOWNLOADED OUR
DIGITAL PATIENT BROCHURE YET?
Download this educational brochure to see how OPDIVO and OPDIVO + YERVOY may be used to treat people with a type of skin cancer called melanoma that has spread or cannot be removed by surgery (advanced melanoma).
Important Facts About OPDIVO® (nivolumab) and OPDIVO + YERVOY® (ipilimumab)
OPDIVO and YERVOY can cause problems that can sometimes become serious or life-threatening and can lead to death. Serious side effects may include lung problems; intestinal problems; (GVHD), that uses donor stem cells (allogeneic). Call or see your healthcare provider right away for any new or worsening signs or symptoms.
Important Facts About OPDIVO® (nivolumab) and OPDIVO + YERVOY® (ipilimumab)
This is a summary of important information that you need to know about OPDIVO and OPDIVO + YERVOY. Your healthcare team can work with you to help answer any questions you may have about these medications. Keep this information in a safe place so you can refer to it before and during your treatment.
Look out for the following
icons as you read:
- Talk to your
healthcare team - Call a healthcare
provider right away - Helpful information
to remember
What is OPDIVO and OPDIVO + YERVOY?
OPDIVO is a prescription medicine used in combination with YERVOY (OPDIVO + YERVOY) to treat:
Adults and children 12 years of age and older who have a type of skin cancer called melanoma, and:
Whose melanoma has spread or cannot be removed by surgery (advanced melanoma).
OPDIVO can be used alone or in combination with YERVOY (OPDIVO + YERVOY).
It is not known if OPDIVO is safe and effective in children younger than 12 years of age with melanoma or MSI-H or dMMR metastatic colorectal cancer.
It is not known if OPDIVO is safe and effective in children for the treatment of any other cancers.
OPDIVO (10 mg/mL) and YERVOY
What is the most important information I should know about OPDIVO + YERVOY?
OPDIVO and YERVOY are medicines that may treat certain cancers by working with your immune system. OPDIVO and YERVOY can cause your immune system to attack normal organs and tissues in any area of your body and can affect the way they work. Some of these problems may happen more often when OPDIVO is used in combination with another therapy.
Get medical help immediately if you develop any of these signs or symptoms or they get worse. It may keep these problems from becoming more serious. Your healthcare team will check you for these problems during treatment and may treat you with corticosteroid or hormone replacement medicines. If you have severe side effects, your healthcare team may also need to delay or completely stop your treatment.
What are the serious side effects of OPDIVO and OPDIVO + YERVOY?
A serious side effect is a side effect that can sometimes become severe or life-threatening and can lead to death. They may happen anytime during treatment or even after your treatment has ended. You may have more than one of these problems at the same time.
Call or see your healthcare provider right away if you develop any new or worse signs or symptoms, including:
Lung problems — Things to look out for may include:
- new or worsening cough
- shortness of breath
- chest pain
Intestinal problems — Things to look out for may include:
- diarrhea (loose stools) or more frequent bowel movements than usual
- stools that are black, tarry, sticky, or have blood or mucus
- severe stomach-area (abdominal)
pain or tenderness
Liver problems — Things to look out for may include:
- yellowing of your skin or the
whites of your eyes - severe nausea or vomiting
- pain on the right side of your
stomach area (abdomen) - dark urine (tea colored)
- bleeding or bruising more easily
than normal
Hormone gland problems — Things to look out for may include:
- headaches that will not go away
or unusual headaches - eye sensitivity to light
- eye problems
- rapid heartbeat
- increased sweating
- extreme tiredness
- weight gain or weight loss
- feeling more hungry or thirsty than usual
- urinating more often than usual
- hair loss
- feeling cold
- constipation
- your voice gets deeper
- dizziness or fainting
- changes in mood or behavior, such as decreased sex drive, irritability, or forgetfulness
Kidney problems — Things to look out for may include:
- decrease in your amount of urine
- blood in your urine
- swelling of your ankles
- loss of appetite
Skin problems — Things to look out for may include:
- rash
- itching
- skin blistering or peeling
- painful sores or ulcers in the mouth or nose, throat, or genital area
Eye problems — Things to look out for may include:
- blurry vision, double vision, or
other vision problems - eye pain or redness
Problems can also happen in other organs and tissues. These are not all the signs and symptoms of immune system problems that can happen with OPDIVO and YERVOY. Call or see your healthcare provider right away for any new or worsening signs or symptoms, which may include:
- Chest pain, irregular heartbeat, shortness of breath, swelling of ankles
- Confusion, sleepiness, memory problems, changes in mood or behavior, stiff neck, balance problems, tingling or numbness of the arms or legs
- Double vision, blurry vision, sensitivity to light, eye pain, changes in eyesight
- Persistent or severe muscle pain or weakness, muscle cramps
- Low red blood cells, bruising
What are the possible side effects of OPDIVO + YERVOY?
OPDIVO and OPDIVO + YERVOY can cause serious side effects, including:
See the previous section, “What is the most important information I should know about OPDIVO + YERVOY?”
Severe infusion reactions — Things to look out for may include:
- chills or shaking
- itching or rash
- flushing
- shortness of breath or wheezing
- dizziness
- feel like passing out
- fever
- back or neck pain
Tell your healthcare team right away if you get these symptoms during an infusion of OPDIVO or YERVOY.
Complications, including graft-versus-host disease (GVHD), of bone marrow (stem cell) transplant that uses donor stem cells (allogeneic). These complications can be severe and can lead to death. These complications may happen if you underwent transplantation either before or after being treated with OPDIVO or YERVOY. Your healthcare provider will monitor you for these complications.
What are the most common side effects?
The most common side effects of OPDIVO when used alone include:
- feeling tired
- rash
- pain in muscles, bones, and joints
- itchy skin
- diarrhea
- nausea
- weakness
- cough
- vomiting
- shortness of breath
- constipation
- decreased appetite
- back pain
- upper respiratory tract infection
- fever
- headache
- stomach-area (abdominal) pain
- urinary tract infection
The most common side effects of OPDIVO when used in combination with YERVOY include:
- feeling tired
- diarrhea
- rash
- itching
- nausea
- pain in muscles, bones,
and joints - fever
- cough
- decreased appetite
- vomiting
- stomach-area (abdominal) pain
- shortness of breath
- upper respiratory tract
infection - headache
- low thyroid hormone
levels (hypothyroidism) - constipation
- decreased weight
- dizziness
These are not all the possible side effects. Talk to your healthcare team or pharmacist for more information. You are encouraged to report side effects of prescription drugs to the FDA. Call 1-800-FDA-1088.
What should I discuss with my healthcare team before receiving OPDIVO or YERVOY?
Tell your healthcare provider about all your medical conditions, including if you:
- have immune system problems such as Crohn’s disease, ulcerative colitis, or lupus
- have received an organ transplant
- have received or plan to receive a stem cell transplant that uses donor stem cells (allogeneic)
- have received radiation treatment to your chest area in the past and have received other medicines that are like OPDIVO
- have a condition that affects your nervous system, such as myasthenia gravis or Guillain-Barré syndrome
- are pregnant or plan to become pregnant. OPDIVO and YERVOY can harm your unborn baby.
- are breastfeeding or plan to breastfeed. It is not known if OPDIVO or YERVOY passes into your breast milk. Do not breastfeed during treatment and for 5 months after your last dose of OPDIVO or YERVOY.
Females who are able to become pregnant:
Your healthcare provider should do a pregnancy test before you start receiving OPDIVO or YERVOY.
- You should use an effective method of birth control during your treatment and for 5 months after the last dose of OPDIVO or YERVOY. Talk to your healthcare provider about birth control methods that you can use during this time.
- Tell your healthcare provider right away if you become pregnant or think you may be pregnant during treatment with OPDIVO or YERVOY. You or your healthcare provider should contact Bristol Myers Squibb at
1-844-593-7869 as soon as you become aware of a pregnancy.
Tell your healthcare provider about all the medicines you take, including:
- prescription medicines
- over-the-counter medicines
- vitamins
- herbal supplements
For more information, please see U.S. Full Prescribing Information and Medication Guide for OPDIVO and U.S. Full Prescribing Information and Medication Guide for YERVOY, or talk to your healthcare team.
Information provided on this website is not a substitute for talking with your healthcare professional.
Your healthcare professional is the best source of information about your disease.
All individuals depicted are models used for illustrative purposes only.
INDICATION
OPDIVO® (nivolumab) is a prescription medicine used to treat adults and children 12 years of age and older with a type of skin cancer called melanoma that has spread or cannot be removed by surgery (advanced melanoma).
OPDIVO® (nivolumab) is a prescription medicine used in combination with YERVOY® (ipilimumab) to treat adults and children 12 years of age and older with a type of skin cancer called melanoma that has spread or cannot be removed by surgery (advanced melanoma).
It is not known if OPDIVO is safe and effective in children younger than 12 years of age with melanoma or MSI-H or dMMR metastatic colorectal cancer.
It is not known if OPDIVO is safe and effective in children for the treatment of any other cancers.
Please see U.S. Full Prescribing Information and Medication Guide for OPDIVO.
Please see U.S. Full Prescribing Information and Medication Guide for YERVOY.
Important Safety Information for OPDIVO® (nivolumab) and OPDIVO + YERVOY® (ipilimumab)
What is the most important information I should know about OPDIVO + YERVOY?
OPDIVO and YERVOY are medicines that may treat certain cancers by working with your immune system. OPDIVO and YERVOY can cause your immune system to attack normal organs and tissues in any area of your body and can affect the way they work. These problems can sometimes become severe or life-threatening and can lead to death. These problems may happen anytime during treatment or even after your treatment has ended. You may have more than one of these problems at the same time. Some of these problems may happen more often when OPDIVO is used in combination with another therapy.
Call or see your healthcare provider right away if you develop any new or worse signs or symptoms, including:
Problems can also happen in other organs and tissues. These are not all of the signs and symptoms of immune system problems that can happen with OPDIVO and YERVOY. Call or see your healthcare provider right away for any new or worsening signs or symptoms, which may include:
Getting medical help right away may help keep these problems from becoming more serious. Your healthcare team will check you for these problems during treatment and may treat you with corticosteroid or hormone replacement medicines. Your healthcare team may also need to delay or completely stop your treatment if you have severe side effects.
Possible side effects of OPDIVO + YERVOY
OPDIVO and OPDIVO + YERVOY can cause serious side effects, including:
The most common side effects of OPDIVO, when used alone, include: feeling tired; rash; pain in muscles, bones, and joints; itchy skin; diarrhea; nausea; weakness; cough; vomiting; shortness of breath; constipation; decreased appetite; back pain; upper respiratory tract infection; fever; headache; stomach-area (abdominal) pain; and urinary tract infection.
The most common side effects of OPDIVO, when used in combination with YERVOY, include: feeling tired; diarrhea; rash; itching; nausea; pain in muscles, bones, and joints; fever; cough; decreased appetite; vomiting; stomach-area (abdominal) pain; shortness of breath; upper respiratory tract infection; headache; low thyroid hormone levels (hypothyroidism); constipation; decreased weight; and dizziness.
These are not all the possible side effects. For more information, ask your healthcare provider or pharmacist. You are encouraged to report side effects of prescription drugs to the FDA. Call 1-800-FDA-1088.
Before receiving OPDIVO or YERVOY, tell your healthcare provider about all of your medical conditions, including if you:
Females who are able to become pregnant:
Your healthcare provider should do a pregnancy test before you start receiving OPDIVO or YERVOY.
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.
Please see U.S. Full Prescribing Information and Medication Guide for OPDIVO.
Please see U.S. Full Prescribing Information and Medication Guide for YERVOY.
You are now leaving this Bristol Myers Squibb site.
This internet site may provide links or references to other sites.
Bristol Myers Squibb has no responsibility for the content of such other sites and is not liable for any damages or injury arising from
that content. Any links to other sites are provided merely as a convenience to the users of this internet site.
Would you like to leave this site?
You are about to leave this Bristol Myers Squibb site. You are being redirected to another Bristol Myers Squibb site.
Would you like to leave this site?
This link is currently not available. Please check back at a later time.